Orion Biotechnology Canada Ltd.
$334,359.93
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2020-2021
Canada
Orion Biotechnology is developing a novel biologic for the treatment of SARS-CoV-2.